Shandong Sanyuan Biotechnology Co.,Ltd.

SZSE:301206 Stock Report

Market Cap: CN¥5.9b

Shandong Sanyuan BiotechnologyLtd Balance Sheet Health

Financial Health criteria checks 6/6

Shandong Sanyuan BiotechnologyLtd has a total shareholder equity of CN¥4.6B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥4.9B and CN¥320.0M respectively.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ration/a
CashCN¥101.63m
EquityCN¥4.56b
Total liabilitiesCN¥320.01m
Total assetsCN¥4.88b

Recent financial health updates

No updates

Recent updates

What You Can Learn From Shandong Sanyuan Biotechnology Co.,Ltd.'s (SZSE:301206) P/S

Apr 06
What You Can Learn From Shandong Sanyuan Biotechnology Co.,Ltd.'s (SZSE:301206) P/S

Financial Position Analysis

Short Term Liabilities: 301206's short term assets (CN¥351.0M) exceed its short term liabilities (CN¥270.9M).

Long Term Liabilities: 301206's short term assets (CN¥351.0M) exceed its long term liabilities (CN¥49.1M).


Debt to Equity History and Analysis

Debt Level: 301206 is debt free.

Reducing Debt: 301206 had no debt 5 years ago.

Debt Coverage: 301206 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 301206 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.